The mTORC2 signaling network: targets and cross-talks
Biochemical Journal · 25.01.2024 · 481 (2) · 45-91
DOI: 10.1042/bcj20220325 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Journal, online erschienen am 25.01.2024. Verfasst von Aparna Ragupathi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, U.S.A. Hauptthemen laut MEDLINE: Signal Transduction, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 120-mal zitiert (Crossref) und nennt 394 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
The mechanistic target of rapamycin, mTOR, controls cell metabolism in response to growth signals and stress stimuli. The cellular functions of mTOR are mediated by two distinct protein complexes, mTOR complex 1 (mTORC1) and mTORC2. Rapamycin and its analogs are currently used in the clinic to treat a variety of diseases and have been instrumental in delineating the functions of its direct target, mTORC1. Despite the lack of a specific mTORC2 inhibitor, genetic studies that disrupt mTORC2 expression unravel the functions of this more elusive mTOR complex. Like mTORC1 which responds to growth signals, mTORC2 is also activated by anabolic signals but is additionally triggered by stress. mTORC2 mediates signals from growth factor receptors and G-protein coupled receptors. How stress conditions such as nutrient limitation modulate mTORC2 activation to allow metabolic reprogramming and ensure cell survival remains poorly understood. A variety of downstream effectors of mTORC2 have been identified but the most well-characterized mTORC2 substrates include Akt, PKC, and SGK, which are members of the AGC protein kinase family. Here, we review how mTORC2 is regulated by cellular stimuli including how compartmentalization and modulation of complex components affect mTORC2 signaling. We elaborate on how phosphorylation of its substrates, particularly the AGC kinases, mediates its diverse functions in growth, proliferation, survival, and differentiation. We discuss other signaling and metabolic components that cross-talk with mTORC2 and the cellular output of these signals. Lastly, we consider how to more effectively target the mTORC2 pathway to treat diseases that have deregulated mTOR signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, U.S.A.
ORCID-Profile: Estela Jacinto
Förderung
- NIGMS NIH HHS
Zitieren
APA
Ragupathi, A., Kim, C., & Jacinto, E. (2024). The mTORC2 signaling network: targets and cross-talks. Biochemical Journal, 481(2), 45-91. https://doi.org/10.1042/bcj20220325
Vancouver
Ragupathi A, Kim C, Jacinto E. The mTORC2 signaling network: targets and cross-talks. Biochemical Journal. 2024;481(2):45-91. doi:10.1042/bcj20220325
BibTeX
@article{Ragupathi2024,
author = {Ragupathi, Aparna and Kim, Christian and Jacinto, Estela},
title = {The mTORC2 signaling network: targets and cross-talks},
journal = {Biochemical Journal},
year = {2024},
volume = {481},
number = {2},
pages = {45--91},
doi = {10.1042/bcj20220325}
}
EUVIMED